Monopar Therapeutics (MNPR) Total liabilities 2016–2025
Monopar Therapeutics (MNPR) total liabilities at each fiscal year-end, per SEC filings.
$2.9MFY2025 · since FY2016: $64,510 → $2.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.9M | -45.0% |
| FY2024 | $5.3M | — |
| FY2019 | $724,165 | +81.2% |
| FY2018 | $399,551 | +28.1% |
| FY2017 | $311,867 | +383.4% |
| FY2016 | $64,510 | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice